DIN 02560771 — ELAHERE 100 MG
ELAHERE is a solution of Mirvetuximab soravtansine marketed by ABBVIE CORPORATION. The full Mirvetuximab soravtansine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02560771
- Brand name
- ELAHERE
- Active ingredient
- Mirvetuximab soravtansine
- Strength
- 100 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- ABBVIE CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Folate receptor-alpha (FRα)-directed antibody-drug conjugate
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.